Skip to main content

Find a clinical trial

Find a clinical trial

Trial status
Trial Phase
Trial type
28 clinical trials grid list download
  • Title Organ Phase Statut Major inclusion criteria Contact
  • 1367.1 An open label, Phase Ia/Ib dose finding study with BI 894999 orally administered once a day in patients with advanced malignancies, with repeated administration in patients with clinical benefit Multiples phase 1 Open any line, RECIST 1.1 Ahmad Hussein Awada
  • AMC303-01 A safety, tolerability and pharmacokinetic dose escalation expansion, Phase I/Ib study of AMC303 as monotherapy in patients with advanced or metastatic, malignant solid tumour of epithelial origin Multiples phase 1/1b Closed any line, RECIST 1.1 Philippe Aftimos
  • BGOG-cx1/ENGOT-cx1 Randomized double-blind phase II study comparing 3-weekly carboplatin (AUC 5 or 6) + paclitaxel 175 mg/m2 with or without concomitant and maintenance Nintedanib in advanced or recurrent cervical carcinoma Utérus phase 2 Closed Second line Joseph Kerger
  • C101 Open, non-controlled, multicenter, first-in-human study for the evaluation of the safety, pharmacokinetics and preliminary antitumor activity of GM102 in patients with advanced pretreated gynecological cancer Multiples phase 1 Closed Any line, RECIST 1.1 Ahmad Hussein Awada
  • CA209358 Non-Comparative, Two-Cohort, Single-Arm, Open-Label, Phase 1/2 Study of Nivolumab (BMS-936558) in Subjects with Virus-Positive and Virus-Negative Solid Tumors Multiples phase 1/2 Closed ECOG 0 or 1 Ahmad Hussein Awada
  • CHIPOR CHIPOR : randomized phase III study evaluating hypertermic intraperitoneal chemotherapy in the treatment of ovarian cancer relapse Ovaire phase 3 Closed Status WHO < 2. Adjuvant Gabriel Liberale
  • EORTC 1658 Qualification of imaging methods to assess cancer drug induced interstitial lung disease (ImageILD) Poumon Closed any line / Lung metastasis Konstantinos Stathopoulos
  • EORTC 55092 Phase IB-II, open label, multicentre feasibility study of pazopanib in combination with Paclitaxel and Carboplatin in patients with platinumrefractory/ resistant ovarian, fallopian tube or peritoneal carcinoma Multiples phase 1/2 Closed Platinium-refractory Joseph Kerger
  • EVICTION A fist-in-human, two-part, open-label, clinical study to assess the safety, tolerability and activity of intravenous doses of ICT01 as monotherapy and in combination with an Immune Checkpoint Inhibitor, in patients with advanced-stage, relapsed/refractory cancer Multiples phase 1 Open Relasped/refractory patient Christiane Jungels
  • I4D-MC-JTJN A Phase 2 Study of Prexasertib in Platinum-Resistant or Refractory Recurrent Ovarian Cancer Ovaire phase 2 Closed Platinium resistant Joseph Kerger
  • I7W-MC-JQBA A Phase 1 Study of LY3127804 as Monotherapy and in Combination with Ramucirumab in Patients with Advanced Solid Tumors Multiples phase 1 Closed RECIST 1.1, after standard trerapy Ahmad Hussein Awada
  • IJB_2672 A Phase 3, Placebo-Controlled, Randomized, Observer-Blinded Study To Evaluate The Efficacy, Safety, And Tolerability Of A Clostridium Difficile Vaccine In Adults 50 Years Of Age And Older Multiples phase 3 Open vaccine, diarrhea, clostridium Mickael Aoun
  • IJB_2728 Improving emotion regulation for patients with metastatic cancer: A pilot study assessing the impact of a multi-component psychological group intervention Tumeurs solides Open Metastatic, any tumors
  • IJB_2732 A Phase 1a/1b Study of an Anti-IDO-1 Agent (LY3381916) Administered Alone or in Combination with Anti-PD-L1 Checkpoint Antibody (LY3300054) in Solid Tumors Multiples phase 1/1b Closed Metastatic, Biopsy mandatory Nuria Kotecki